These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 5517476)
21. [Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics]. Timofeev NN; Kondrashenko VT; Nemtseva NIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(6):906-13. PubMed ID: 5723252 [No Abstract] [Full Text] [Related]
22. [Unithiol and D-penicillamine as psychic energizers and corrective agents in treatment with neuroleptics]. Vaĭnshteĭn IA Vrach Delo; 1972 Jul; 7():115-8. PubMed ID: 5083738 [No Abstract] [Full Text] [Related]
23. [Effect of neuroleptics on adrenaline and histamine skin reaction in simple schizophrenics]. Jedrzejczak M Ann Acad Med Stetin; 1975; 21():357-89. PubMed ID: 1229947 [No Abstract] [Full Text] [Related]
24. Prediction of the therapeutic effects in schizophrenic psychoses by means of DAF. Bsstecký J; Vinar O; Tosovský J Act Nerv Super (Praha); 1973 Aug; 15(3):165-7. PubMed ID: 4769129 [No Abstract] [Full Text] [Related]
25. [Clinical study of oxaflumazine; its place among the neuroleptics]. Deniker P; Ginestet D; Peron-Magnan P; Colonna L; Loo H Therapie; 1971; 26(1):227-33. PubMed ID: 5554766 [No Abstract] [Full Text] [Related]
27. [Excitability of the vestibular system in schizophrenic patients treated with neuroleptics]. Szymczewska J Ann Acad Med Stetin; 1971; 17():429-50. PubMed ID: 5317128 [No Abstract] [Full Text] [Related]
28. [Blood serum tryptophan in schizophrenic patients and the dependence of its level on treatment with neuroleptics]. Szafranek J Ann Acad Med Stetin; 1970; 16():519-34. PubMed ID: 5525985 [No Abstract] [Full Text] [Related]
30. [Evaluation of thiothixene in the therapy of chronic schizophrenia]. Romaszewska K; Piotrowski A Psychiatr Pol; 1970; 4(1):69-71. PubMed ID: 5421205 [No Abstract] [Full Text] [Related]
31. [Therapeutic pathomorphology during the terminal stages of schizophrenia]. Vartanian FE Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):250-7. PubMed ID: 5661308 [No Abstract] [Full Text] [Related]
32. [Lesions of the central nervous system in the course of neuroleptic treatment]. Lewicka-Wysocka H Psychiatr Pol; 1972; 6(1):87-91. PubMed ID: 5012386 [No Abstract] [Full Text] [Related]
33. [Therapeutic results and complications in the use of lyogen in long-term schizophrenics]. Kutsenok BM; Zolotnitskiĭ RI Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1578-83. PubMed ID: 5490156 [No Abstract] [Full Text] [Related]
34. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties]. Arushanian EB Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251 [No Abstract] [Full Text] [Related]
35. [On differentiated therapy of schizophrenia]. Zhislin SG Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65(10):1507-16. PubMed ID: 5873606 [No Abstract] [Full Text] [Related]
37. [Therapeutic test with a new antipsychotic drug (P-4657-B)]. Querol M; Garcia M; Alarcon R; Infante A; Reyna L Rev Neuropsiquiatr; 1968 Jun; 31(2):73-82. PubMed ID: 5743725 [No Abstract] [Full Text] [Related]
38. [New approaches in correcting disorders of higher integrative brain functions in the pharmacotherapy of arterial hypertension with propranolol]. Petrov VI; Solomin MIu; Gorbunov SG Eksp Klin Farmakol; 1998; 61(5):10-2. PubMed ID: 9854623 [TBL] [Abstract][Full Text] [Related]
39. [Unexpected therapeutic effects of tybamate in psychoses]. Turns D; Denber HC; Turns CN Ann Med Psychol (Paris); 1968 Jul; 2(2):216-20. PubMed ID: 5684178 [No Abstract] [Full Text] [Related]
40. A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders. Wyatt RJ; Torgow JS J Psychiatr Res; 1977; 13(2):91-8. PubMed ID: 320322 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]